Migraine Management (EP. 8)

Join us as we discuss updates in the treatment and prevention of migraines with Dr. Alivia Price, a board certified neurology clinical pharmacy specialist. **30 minutes of non-live CE credit is available at no charge to APA members once you've listened to this episode and the episode bonus content.** Target Audience: Pharmacists and Pharmacy TechniciansActivity Type: Knowledge-based CEU:.5 contact hours (.05 CEU) of CPE creditACPE UAN: 0178-0000-24-105-H01-P/TActivity Type: Knowledge-basedInitial Release Date: May 6, 2024Expiration Date: May 6, 2026 Learning Objectives: At the completion of this activity, the pharmacist will be able to: Determine appropriateness of utilizing various abortive and/or preventative therapies in a migraine medication regimen for a specific patient  Understand key differences in the mechanisms of action between triptans and CGRP antagonists Describe the specific characteristics for administration and monitoring of CGRP targeting medications used for migraine prevention and abortive treatment. At the completion of this activity, the technician will be able to: Recognize appropriateness of utilizing various abortive and/or preventative therapies in a migraine medication regimen for a specific patient  Understand key differences in the mechanisms of action between triptans and CGRP antagonists Describe the specific characteristics for administration and monitoring of CGRP targeting medications used for migraine prevention and abortive treatment. Lecture Panda link to claim credit: Migraine Management Thanks for listening! References: Charles AC, et al. Headache. 2024;64(4):333-341. doi: 10.1111/head.14692 Ailani J, et al. Headache. 2021;61(7):1021-1039 doi: 10.1111/head.14153 Burch, et al. Headache. 2018;58(4):496-505. doi: 10.1111/head.13281 Tfelt-Hansen P, et al. Drugs. 2000;60(6):1259. doi: 10.2165/00003495-200060060-00003 Tepper SJ. Headache. 2018;58 Suppl 3:238-275. doi: 10.1111/head.13379 Bucklan J, et al. Cleveland Clinic Journal of Medicine. 2020;87(4):211-218. doi: http://dx.doi.org/10.3949/ccjm.87a.19048